The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Ally Financial Inc | Common | 02005N100 | 78,595 | 3,504,000 | SH | SOLE | SOLE | 3,504,000 | 0 | 0 | |
ANTERO RESOURCES CORP | Common | 03674X106 | 44,358 | 1,291,733 | SH | SOLE | SOLE | 1,291,733 | 0 | 0 | |
Ardelyx Inc | Common | 039697107 | 2,186 | 136,866 | SH | SOLE | SOLE | 136,866 | 0 | 0 | |
Cheniere Energy Inc | Common | 16411R208 | 66,552 | 960,900 | SH | SOLE | SOLE | 960,900 | 0 | 0 | |
Cresud SACIF y A | Common | 226406106 | 6,324 | 485,711 | SH | SOLE | SOLE | 485,711 | 0 | 0 | |
IRSA Inversiones y Representaciones SA | Common | 450047204 | 20,589 | 1,146,996 | SH | SOLE | SOLE | 1,146,996 | 0 | 0 | |
Keryx Biopharmaceuticals Inc | Common | 492515101 | 16,026 | 1,605,800 | SH | SOLE | SOLE | 1,605,800 | 0 | 0 | |
Manitowoc Co Inc/The | Common | 563571108 | 71,449 | 3,645,349 | SH | SOLE | SOLE | 3,645,349 | 0 | 0 | |
YPF SA | Common | 984245100 | 38,498 | 1,403,494 | SH | SOLE | SOLE | 1,403,494 | 0 | 0 |